Federal inspectors found the facility received 180 tablets of oxycodone for Resident #51 between July 10 and August 15. Records showed she received only 78 tablets during that period. When a licensed practical nurse checked the narcotic supply on August 29, no oxycodone remained available for the resident.
The math didn't work. She should have had 125 tablets left.
Regional Nurse #200 confirmed during a September 17 interview that the facility "did not have a summary or conclusion of their investigation into the allegation of missing narcotics for Resident #51." The initial complaint came in on September 3, nearly five weeks after the discrepancy first appeared in medication counts.
The missing pills coincided with suspicious narcotic logging by RN #227 on August 28. That nurse signed in only "one card and one sheet of Alprazolam for Resident #81" despite receiving two sheets and two cards containing 45 pills total, according to controlled substance records reviewed by inspectors.
LPN/Unit Manager #175 explained the significance during her September 17 interview: signing in fewer narcotics than actually received "would make the count wrong unless a card and sheet were removed by someone."
By documenting fewer narcotics than delivered, someone could remove medications belonging to another resident without the overall count appearing off.
RN #227 continued working regular day shifts on B-Hall through September 16 and 17, even as administrators knew about the resident's theft allegations.
Resident #51 went without her prescribed oxycodone from August 28 through August 31. The pharmacy delivered replacement medication on August 31, but the 102 missing tablets were never located or explained.
The resident made her concerns known to staff. Regional Nurse #200 said during her interview that she "was notified last night that Resident #51 stated she did not receive a pain pill." The unit manager had called RN #227 to verify medication administration, but no formal investigation followed.
More troubling, Regional Nurse #200 confirmed she "was not aware that Resident #51 had stated that RN #227 was stealing her medications" until much later in the process.
The facility's response proved inadequate across multiple fronts. Administrators drug-tested RN #227 on September 6, which came back negative. But they never investigated the Alprazolam logging discrepancy that occurred the same day the oxycodone went missing.
Regional Nurse #200 described the situation bluntly: after determining "what a mess it was," she provided education to nursing staff on September 3. The pharmacy was notified the same day but "was not involved in doing any investigation into missing narcotics."
The facility's own policy, last revised in 2017, prohibits "misappropriation of resident property," defined as "the deliberate misplacement, exploitation, or wrongful temporary or permanent use of a resident's belongings or money without the resident's consent."
Controlled substances belong to individual residents once prescribed and delivered. The missing oxycodone represented 102 doses of pain relief that Resident #51 never received.
Federal inspectors documented the narcotic discrepancies through detailed record reviews. Pharmacy delivery reports showed precise dates and quantities: 30 tablets delivered July 10, July 18, July 27, August 2, August 9, and August 15. Another 30 tablets arrived August 23.
Medication administration records revealed the resident received seven tablets between August 24 and August 29. The remaining 125 tablets should have been available when LPN #195 found none on August 29.
The Alprazolam incident provided additional context. Controlled medication shift logs showed RN #227 signed in 45 pills for Resident #81 on August 28, but documented receiving only one card and one sheet instead of the actual two cards and two sheets delivered.
This created what LPN/Unit Manager #175 called a counting vulnerability. Extra medications could be removed without detection if fewer narcotics were logged than actually received.
The timeline proved significant. RN #227's improper Alprazolam logging occurred on August 28. Resident #51's oxycodone disappeared by August 29. She went without pain medication until August 31.
Regional Nurse #200 acknowledged the facility failed to investigate the Alprazolam discrepancy despite its connection to the missing oxycodone. She confirmed both incidents involved the same nurse during the same time period.
The inspection revealed broader systemic problems with narcotic oversight. Multiple complaint numbers were associated with the deficiency: 2623748, 2615387, 2608772, and 2608729, suggesting ongoing concerns about medication management.
Resident #51's direct accusation that RN #227 was stealing her medications never triggered the thorough investigation required by federal regulations. Instead, administrators made a phone call to verify medication administration and conducted brief staff education.
The facility classified the violation as causing "minimal harm or potential for actual harm" affecting "few" residents. But Resident #51 experienced four days without prescribed pain medication while 102 doses of oxycodone remained unaccounted for.
Federal inspectors found the facility in violation of requirements to protect residents from misappropriation of their property. The missing narcotics, improper logging, and inadequate investigation represented multiple failures in a single case.
RN #227 remained on duty throughout the inspection period. Resident #51's pain medication was eventually replaced, but the original 102 tablets were never found or explained.
Full Inspection Report
The details above represent a summary of key findings. View the complete inspection report for Country Lane Gardens Rehab & Nursing Ctr from 2025-10-15 including all violations, facility responses, and corrective action plans.
Additional Resources
- View all inspection reports for Country Lane Gardens Rehab & Nursing Ctr
- Browse all OH nursing home inspections